Efficacy of Mifepristone (RU-486) in the Treatment of Bipolar Depression.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Mifepristone (Primary)
- Indications Bipolar disorders
- Focus Biomarker; Pharmacodynamics
- 01 Dec 2012 Primary endpoint 'Cambridge-Neuropsychological-Test-Automated-Battery' has not been met.
- 24 Sep 2008 Planned end date changed from Sep 2009 to Dec 2010 as reported by ClinicalTrials.gov.
- 24 Sep 2008 Planned end date changed from Sep 2009 to Dec 2010 as reported by ClinicalTrials.gov.